<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04538768</url>
  </required_header>
  <id_info>
    <org_study_id>20082020</org_study_id>
    <nct_id>NCT04538768</nct_id>
  </id_info>
  <brief_title>Prevention of Lateral Incisional Hernia After Stomal Closure Using P4HB Retro-muscular Mesh</brief_title>
  <official_title>Prevention of Lateral Incisional Hernia After Stomal Closure Using P4HB Retro-muscular Mesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Buccheri La Ferla Hospital, Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Buccheri La Ferla Hospital, Palermo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine whether the use of the P4HB retro muscular mesh can&#xD;
      prevent the lateral incisional hernia after stomal closure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rate of postoperative lateral incisional hernia after P4HB mesh placement vs direct fascia suture.</measure>
    <time_frame>1 week to 18 months after surgery</time_frame>
    <description>the outcome 1 will be assessed through clinical examination during follow up time. when the suspicion of incisional hernia will be hypothesized the patients will be conducted to perform US of the abdomen and CT scan of the abdomen if strictly required to confirm the suspicion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>surgical operation time in P4HB mesh placement group vs direct fascia suture group.</measure>
    <time_frame>intraoperative</time_frame>
    <description>outcome 2 will be assessed through the measurement of the length of surgical operation. The length of the surgical operation will be measured in minutes from the incision of the skin to the suture of the skin. data will be compared with those of the control arm (direct fascia suture) to understand the feasibility of the technique proposed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay in P4HB mesh placement group vs direct fascia suture group.</measure>
    <time_frame>From the starting date of the study until the date of its completion, assessed up to 18 months&quot;</time_frame>
    <description>outcome 3 will be assessed through the measurement of the length of the hospital stay. The length of hospital stay will be measured in days from admission to dimission of the patient. Data will be compared with those of the control arm (direct fascia suture).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of surgical site infection in P4HB mesh placement group vs direct fascia suture group.</measure>
    <time_frame>1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery</time_frame>
    <description>outcome 4 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complication such as surgical site infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of seroma formation in P4HB mesh placement group vs direct fascia suture group.</measure>
    <time_frame>1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery</time_frame>
    <description>outcome 5 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as seroma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of hematoma formation in P4HB mesh placement group vs direct fascia suture group.</measure>
    <time_frame>1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery</time_frame>
    <description>outcome 6 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as hematoma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of quality of life (QoL) through QoL scale in P4HB mesh placement group vs direct fascia suture group.</measure>
    <time_frame>18 months after surgery.</time_frame>
    <description>outcome 7 will be assessed through assessment of the postoperative QoL. The SF-36 questionnaire will be administered post-operatively.&#xD;
The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life.&#xD;
The SF-36, as described in the name, is a 36-item patient-reported questionnaire that covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost effectiveness analysis of the P4HB mesh augmentation technique vs direct fascia suture group.</measure>
    <time_frame>through study completion, an average of 1 year .</time_frame>
    <description>the outcome 8 will be assessed through the collection of data about the total costs for the surgical operation and the hospitalization considering materials and mesh used. The analysis will be used to compare the costs of the technique proposed with those of the incisional hernia management in order to conduct a cost effectiveness analysis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Incisional LLQ Hernia</condition>
  <arm_group>
    <arm_group_label>Mesh Augmentated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Direct Suture</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mesh augmentation</intervention_name>
    <description>P4HB retromuscular mesh placement for prevention of lateral incisional hernia after stomal closure</description>
    <arm_group_label>Mesh Augmentated</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Direct suture</intervention_name>
    <description>direct fascia suture</description>
    <arm_group_label>Direct Suture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients &gt; 18 y.o.&#xD;
&#xD;
          -  stomal closure&#xD;
&#xD;
          -  elective surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients &lt; 18 y.o.&#xD;
&#xD;
          -  emergency surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leo Licari, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ospedale Buccheri La Ferla Palermo; University of Palermo - Department of Surgical, Oncological and Oral Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cosimo Callari, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ospedale Buccheri La Ferla Palermo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leo Licari, MD</last_name>
    <phone>+39 3401710089</phone>
    <email>lele.licari@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cosimo Callari, MD</last_name>
    <phone>+39 339 4574404</phone>
    <email>cosimo.callari@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale Buccheri La Ferla Palermo</name>
      <address>
        <city>Palermo</city>
        <zip>90100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Leo Licari, MD</last_name>
      <phone>+39 3401710089</phone>
      <email>lele.licari@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Cosimo Callari, MD</last_name>
      <phone>+39 3394574404</phone>
      <email>cosimo.callari@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Buccheri La Ferla Hospital, Palermo</investigator_affiliation>
    <investigator_full_name>Leo Licari</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>lateral incisional hernia</keyword>
  <keyword>mesh augmentation</keyword>
  <keyword>prevention</keyword>
  <keyword>stomal closure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Incisional Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

